Enhanced Vaccine for Necrotic Enteritis in Poultry

An improved vaccine composition and delivery system for protecting poultry from necrotic enteritis, offering enhanced safety, efficiency, and immune response.

The original patent disclosed a vaccine for preventing necrotic enteritis in poultry, but it had limitations in terms of immune response, safety, and production efficiency. The new inventive concept addresses these limitations by introducing an adjuvant-enhanced vaccine composition, a co-administered adjuvant for immune response enhancement, a plant-based expression system for production, a mutated non-toxic NetB toxin, and an oral vaccine delivery system.

The enhanced vaccine composition comprises a PlcC-NetB fusion protein and an adjuvant, which stimulates a stronger immune response against the NetB toxin. The co-administered adjuvant enhances the production of antibodies against the NetB toxin, providing better protection against necrotic enteritis. The plant-based expression system enables more efficient and cost-effective production of the PlcC-NetB fusion protein. The mutated non-toxic NetB toxin retains its immunogenic properties while eliminating the risk of toxicity. The oral vaccine delivery system facilitates easier administration and uptake of the vaccine by poultry.

The new claims introduce a novel adjuvant-enhanced vaccine composition, a co-administered adjuvant, a plant-based expression system, a mutated non-toxic NetB toxin, and an oral vaccine delivery system, which are not obvious from the original patent and provide significant improvements over the existing vaccine.

Alternative embodiments may include different adjuvants, expression systems, or delivery vehicles. Variations may involve using different protein units, linkers, or mutations to achieve similar improvements in immune response, safety, and efficiency.

The enhanced vaccine composition and delivery system have significant commercial potential in the poultry industry, offering improved protection against necrotic enteritis, reduced mortality rates, and increased productivity. The target market includes poultry farms, vaccine manufacturers, and animal health companies.